UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

S2k-Leitlinie Haut- und WeichgewebeinfektionenAuszug aus "Kalkulierte parenterale Initialtherapie bakterieller Erkrankungen bei Erwachsenen - Update 2018"

Journal der Deutschen Dermatologischen Gesellschaft, 2019-03, Vol.17 (3), p.345-371

2019

Volltextzugriff (PDF)

5-Oxoproline acidosis caused by acetaminophen and flucloxacillin treatment – a case report

Acute Medicine Journal, 2022-01, Vol.21 (1), p.47-49

2022

Volltextzugriff (PDF)

Development of mouse models with restricted HLA-B∗57:01 presentation for the study of flucloxacillin-driven T-cell activation and tolerance in liver injury

Journal of allergy and clinical immunology, 2023-08, Vol.152 (2), p.486-499.e7

2023

Volltextzugriff (PDF)

Oral Flucloxacillin for Staphylococcal Osteomyelitis: Obsolete or Underused?

Journal of bone and joint infection, 2020, Vol.5 (1), p.25-27

2020

Volltextzugriff (PDF)

FLUCLOXACILLIN INDUCED ACUTE EOSINOPHILIC PNEUMONIA

Respirology (Carlton, Vic.), 2019-11, Vol.24 (S2), p.4-5

2019

Volltextzugriff (PDF)

Localised bullous urticaria presenting as a pompholyx‐like eruption in the context of flucloxacillin

Australasian journal of dermatology, 2022-08, Vol.63 (3), p.e277-e279

2022

Volltextzugriff (PDF)

Restricted vancomycin policy for staphylococcal late onset sepsis in a Portuguese neonatal intensive care unit

Portuguese journal of pediatrics (Online), 2023-07, Vol.54 (3)

2023

Volltextzugriff (PDF)

Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2020-02, Vol.323 (6), p.527

2020

Volltextzugriff (PDF)

Hypokalaemia in patients treated with intravenous flucloxacillin: Incidence and risk factors

British journal of clinical pharmacology, 2022-06, Vol.88 (6), p.2938-2945

2022

Volltextzugriff (PDF)

Cefazolin versus anti-staphylococcal penicillins for the treatment of patients with Staphylococcus aureus bacteraemia

Clinical microbiology and infection, 2019-07, Vol.25 (7), p.818-827

2019

Volltextzugriff (PDF)

Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy--author's response

Journal of antimicrobial chemotherapy, 2012-12, Vol.67 (12), p.3017-3017

Sandoe, J. A. T.

2012

Volltextzugriff (PDF)

Alterations in the HLA-B57:01 Immunopeptidome by Flucloxacillin and Immunogenicity of Drug-Haptenated Peptides

Frontiers in immunology, 2021-02, Vol.11, p.629399

2021

Volltextzugriff (PDF)

Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines

Frontiers in pharmacology, 2020-09, Vol.11, p.567048

2020

Volltextzugriff (PDF)

Oral Flucloxacillin for Treating Osteomyelitis: A Narrative Review of Clinical Practice

Journal of bone and joint infection, 2020, Vol.5 (1), p.16-24

2020

Volltextzugriff (PDF)

Antibiotic utilisation in primary and revision total hip replacement patients: A registry linkage cohort study of 106253 patients using the Australian Orthopaedic Association National Joint Replacement Registry

Pharmacoepidemiology and drug safety, 2023-02, Vol.32 (2), p.238-247

2023

Volltextzugriff (PDF)

Prevalence of adverse drug reactions in the primary care setting: A systematic review and meta-analysis

PloS one, 2021-05, Vol.16 (5), p.e0252161

2021

Volltextzugriff (PDF)

It cuts both ways: A single-center retrospective review describing a three-way interaction between flucloxacillin, voriconazole and tacrolimus

International journal of antimicrobial agents, 2023-09, Vol.62 (3), p.106908-106908, Article 106908

2023

Volltextzugriff (PDF)

HLA-B5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin

Nature genetics, 2009-07, Vol.41 (7), p.816-819

2009

Volltextzugriff (PDF)

P111 Penicillin allergy in liver transplantation recipients and a pilot programme of de-labelling

Gut, 2023-09, Vol.72 (Suppl 3), p.A86-A86

2023

Volltextzugriff (PDF)

A meta-analysis of protein binding of flucloxacillin in healthy volunteers and hospitalized patients

Clinical microbiology and infection, 2022-03, Vol.28 (3), p.446.e1-446.e7

2022

Volltextzugriff (PDF)

Intravenous ceftriaxone at home versus intravenous flucloxacillin in hospital for children with cellulitis: a cost-effectiveness analysis

The Lancet infectious diseases, 2019-10, Vol.19 (10), p.1101-1108

2019

Volltextzugriff (PDF)

Polygenic architecture informs potential vulnerability to drug-induced liver injury

Nature medicine, 2020-10, Vol.26 (10), p.1541-1548

2020

Volltextzugriff (PDF)

Exosomal Transport of Hepatocyte‐Derived Drug‐Modified Proteins to the Immune System

Hepatology (Baltimore, Md.), 2019-11, Vol.70 (5), p.1732-1749

2019

Volltextzugriff (PDF)

Identification of flucloxacillin-modified hepatocellular proteins: implications in flucloxacillin-induced liver injury

Toxicological sciences, 2023-03, Vol.192 (1), p.106-116

2023

Volltextzugriff (PDF)

Pharmacokinetics of anti-infective agents during CytoSorb hemoadsorption

Scientific reports, 2021-05, Vol.11 (1), p.10493-9, Article 10493

2021

Volltextzugriff (PDF)

1 – 25 von 344

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(310)
Mit Volltextzugriff
(274)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Flucloxacillin
(325)
Science & Technology
(251)
Life Sciences & Biomedicine
(231)
Humans
(151)
Antibiotics
(133)
Pharmacology & Pharmacy
(92)
Penicillin
(84)
Female
(81)
Male
(76)
Infectious Diseases
(60)
Patients
(50)
Biological And Medical Sciences
(48)
Medical Sciences
(48)
Anti-Bacterial Agents - Therapeutic Use
(47)
Aged
(46)
Adult
(45)
Middle Aged
(43)
Pharmacology. Drug Treatments
(40)
Staphylococcus Aureus
(40)
Amoxicillin
(37)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

S2k-Leitlinie Haut- und WeichgewebeinfektionenAuszug aus "Kalkulierte parenterale Initialtherapie bakterieller Erkrankungen bei Erwachsenen - Update 2018"

5-Oxoproline acidosis caused by acetaminophen and flucloxacillin treatment – a case report

Development of mouse models with restricted HLA-B∗57:01 presentation for the study of flucloxacillin-driven T-cell activation and tolerance in liver injury

Oral Flucloxacillin for Staphylococcal Osteomyelitis: Obsolete or Underused?

FLUCLOXACILLIN INDUCED ACUTE EOSINOPHILIC PNEUMONIA

Localised bullous urticaria presenting as a pompholyx‐like eruption in the context of flucloxacillin

Restricted vancomycin policy for staphylococcal late onset sepsis in a Portuguese neonatal intensive care unit

Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial

Hypokalaemia in patients treated with intravenous flucloxacillin: Incidence and risk factors

Cefazolin versus anti-staphylococcal penicillins for the treatment of patients with Staphylococcus aureus bacteraemia

Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy--author's response

Alterations in the HLA-B57:01 Immunopeptidome by Flucloxacillin and Immunogenicity of Drug-Haptenated Peptides

Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines

Oral Flucloxacillin for Treating Osteomyelitis: A Narrative Review of Clinical Practice

Antibiotic utilisation in primary and revision total hip replacement patients: A registry linkage cohort study of 106253 patients using the Australian Orthopaedic Association National Joint Replacement Registry

Prevalence of adverse drug reactions in the primary care setting: A systematic review and meta-analysis

It cuts both ways: A single-center retrospective review describing a three-way interaction between flucloxacillin, voriconazole and tacrolimus

HLA-B5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin

P111 Penicillin allergy in liver transplantation recipients and a pilot programme of de-labelling

A meta-analysis of protein binding of flucloxacillin in healthy volunteers and hospitalized patients

Intravenous ceftriaxone at home versus intravenous flucloxacillin in hospital for children with cellulitis: a cost-effectiveness analysis

Polygenic architecture informs potential vulnerability to drug-induced liver injury

Exosomal Transport of Hepatocyte‐Derived Drug‐Modified Proteins to the Immune System

Identification of flucloxacillin-modified hepatocellular proteins: implications in flucloxacillin-induced liver injury

Pharmacokinetics of anti-infective agents during CytoSorb hemoadsorption

Suchergebnisse filtern